Metraipolis › archive › dc_49b000ee31bc
The Prognostic and Predictive Value of Body Mass Index in Patients with HR+/HER2- Breast Cancer Treated with CDK4/6 Inhibitors: A Systematic Literature Review — Europe PMC PMID:41514594
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41514594
- DOI
- 10.3390/cancers18010081
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T09:54:55.186Z
- SHA-256 of the archived text
140b2c06323d44127ccf10d1df3197a6f361580b7ee6255c36631139327fc9f7- Stable URL of this page
https://metraipolis.com/documento/dc_49b000ee31bc
How to cite
The Prognostic and Predictive Value of Body Mass Index in Patients with HR+/HER2- Breast Cancer Treated with CDK4/6 Inhibitors: A Systematic Literature Review — Europe PMC PMID:41514594 — Europe PMC (en), https://europepmc.org/article/MED/41514594 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_49b000ee31bc (Metraipolis archive dc_49b000ee31bc, sha256 140b2c06323d44127ccf10d1df3197a6f361580b7ee6255c36631139327fc9f7)
BibTeX
@misc{dc49b000ee31bc,
title = {The Prognostic and Predictive Value of Body Mass Index in Patients with HR+/HER2- Breast Cancer Treated with CDK4/6 Inhibitors: A Systematic Literature Review — Europe PMC PMID:41514594},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41514594},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_49b000ee31bc; sha256 140b2c06323d44127ccf10d1df3197a6f361580b7ee6255c36631139327fc9f7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41514594. Agents can read the archived copy with the MCP tool read_document.